In late 2019, China notified the World Health Organization (WHO) of a novel strain of coronavirus. This virus, now named SARS-CoV-2, targets the epithelial cells of the respiratory tract and causes infection that can lead to Coronavirus disease 2019 (COVID-19). Siemens Healthineers new molecular assay uses real-time PCR to detect RNA from this virus.
Emergent SARS-CoV-2 Variants
As part of our ongoing Global Surveillance Program, the FTD SARS-CoV-2 Assay1 has been shown to detect emergent SARS-CoV-2 variants.
Explore our dual-target design for the detection of SARS-CoV-2
Características e Benefícios
- Kit comprised of a single-well dual target assay for the specific detection of SARS-CoV-2 (COVID-19)
- Designed for high sensitivity, specificity, and inclusivity
- Covers highly conserved regions within ORF1ab and N gene
- Uses the same assay setup protocol and thermal-cycling profile as all FTD respiratory disease kits